CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,050 | +27.4% | 555,763 | -0.9% | 0.00% | +100.0% |
| Q2 2023 | $824 | -26.1% | 560,743 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $1,115 | -14.8% | 571,663 | -1.8% | 0.00% | -50.0% |
| Q4 2022 | $1,309 | -99.9% | 581,963 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $1,438,000 | +11.4% | 596,863 | -4.1% | 0.00% | 0.0% |
| Q2 2022 | $1,291,000 | -29.0% | 622,228 | -3.5% | 0.00% | 0.0% |
| Q1 2022 | $1,818,000 | -35.8% | 644,763 | +6.3% | 0.00% | -50.0% |
| Q4 2021 | $2,833,000 | +59.1% | 606,663 | -8.7% | 0.00% | +100.0% |
| Q3 2021 | $1,781,000 | -10.8% | 664,564 | -5.3% | 0.00% | 0.0% |
| Q2 2021 | $1,996,000 | -12.5% | 701,463 | -6.9% | 0.00% | -33.3% |
| Q1 2021 | $2,282,000 | +14.6% | 753,053 | +11.5% | 0.00% | +50.0% |
| Q4 2020 | $1,992,000 | +3.5% | 675,159 | +12.6% | 0.00% | 0.0% |
| Q3 2020 | $1,925,000 | -3.6% | 599,658 | +0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,996,000 | +16.6% | 599,458 | +27.1% | 0.00% | 0.0% |
| Q1 2020 | $1,712,000 | -29.2% | 471,658 | +0.5% | 0.00% | 0.0% |
| Q4 2019 | $2,417,000 | -13.1% | 469,338 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,782,000 | -1.1% | 469,138 | +6.2% | 0.00% | 0.0% |
| Q2 2019 | $2,813,000 | +23.9% | 441,577 | +13.0% | 0.00% | 0.0% |
| Q1 2019 | $2,270,000 | -1.3% | 390,777 | +2.5% | 0.00% | -33.3% |
| Q4 2018 | $2,300,000 | +5.6% | 381,374 | -0.0% | 0.00% | +50.0% |
| Q3 2018 | $2,178,000 | -53.4% | 381,471 | -47.8% | 0.00% | -33.3% |
| Q2 2018 | $4,673,000 | +97.9% | 730,709 | +106.7% | 0.00% | 0.0% |
| Q1 2018 | $2,361,000 | -2.9% | 353,500 | +7.0% | 0.00% | 0.0% |
| Q4 2017 | $2,431,000 | +9.0% | 330,300 | +4.5% | 0.00% | 0.0% |
| Q3 2017 | $2,231,000 | +9.6% | 316,005 | +8.6% | 0.00% | 0.0% |
| Q2 2017 | $2,036,000 | +8.6% | 290,853 | +7.6% | 0.00% | 0.0% |
| Q1 2017 | $1,875,000 | +32.6% | 270,240 | +5.2% | 0.00% | +50.0% |
| Q4 2016 | $1,414,000 | +14.2% | 257,000 | +4.0% | 0.00% | 0.0% |
| Q3 2016 | $1,238,000 | +16.9% | 247,100 | +5.0% | 0.00% | 0.0% |
| Q2 2016 | $1,059,000 | +6.0% | 235,300 | +5.7% | 0.00% | 0.0% |
| Q1 2016 | $999,000 | -12.5% | 222,600 | +2.5% | 0.00% | 0.0% |
| Q4 2015 | $1,142,000 | -0.3% | 217,200 | +9.4% | 0.00% | -33.3% |
| Q3 2015 | $1,146,000 | -18.5% | 198,580 | +1.0% | 0.00% | 0.0% |
| Q2 2015 | $1,406,000 | +24.1% | 196,700 | +15.6% | 0.00% | +50.0% |
| Q1 2015 | $1,133,000 | +56.7% | 170,188 | +40.8% | 0.00% | 0.0% |
| Q4 2014 | $723,000 | +74.2% | 120,900 | +43.8% | 0.00% | +100.0% |
| Q3 2014 | $415,000 | +19.9% | 84,100 | +9.5% | 0.00% | 0.0% |
| Q2 2014 | $346,000 | -19.5% | 76,800 | -19.7% | 0.00% | 0.0% |
| Q1 2014 | $430,000 | -37.0% | 95,597 | -28.3% | 0.00% | -50.0% |
| Q4 2013 | $682,000 | -15.3% | 133,400 | -24.9% | 0.00% | 0.0% |
| Q3 2013 | $805,000 | -37.2% | 177,662 | -29.2% | 0.00% | -33.3% |
| Q2 2013 | $1,282,000 | – | 250,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 188,703 | $557,000 | 0.43% |
| Sterling Financial Planning, Inc. | 22,031 | $65,000 | 0.05% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 165,495 | $488,000 | 0.04% |
| Ariel Investments | 821,096 | $2,422,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,287 | $445,000 | 0.01% |
| Renaissance Technologies | 675,159 | $1,992,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 781,891 | $2,299,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $9,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 105,018 | $310,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 53,441 | $157,000 | 0.00% |